News: September, 2012

Photo: Lung Cancer Partnership

Friday, September 28th, 2012

Caroline Nebhan, right, a fourth-year student in the M.D./Ph.D. training program, explains a cancer research experiment to advocates from the National Lung Cancer Partnership who toured Vanderbilt-Ingram Cancer Center during their recent meeting in Nashville. Nebhan, who works in the research laboratory of William Pao, M.D., Ph.D., is studying the effects of a specific cancer […]

Target Acquired for Aggressive Tumor

Friday, September 28th, 2012

Angiosarcoma, a rare, aggressive tumor that arises from cells that line blood vessels, has a mortality rate of around 80 percent. Because of their constant contact with the blood stream, these tumors can spread quickly and freely throughout the body. The INK4a/ARF locus on chromosome 9 – a region that encodes tumor suppressor proteins – […]

LifeFlight goes pink for breast cancer awareness

Friday, September 28th, 2012

Nashville (Tenn.) – Vanderbilt LifeFlight is going pink during October to show its support for breast cancer awareness.LifeFlight medical crews will wear a special pink name badge on their flight suits and other staff will wear pink golf shirts. October is designated as National Breast Cancer Awareness Month, dedicated to raising awareness and educating individuals […]

Grant Renewal Boosts GI Cancer Research Program

Friday, September 21st, 2012

Vanderbilt-Ingram Cancer Center’s gastrointestinal Specialized Program of Research Excellence (SPORE) has been awarded its third round of funding by the National Cancer Institute (NCI). “We decided to roll the dice and propose high-risk, high-reward projects,” said Robert Coffey Jr., M.D., Ingram Professor of Cancer Research, professor of Medicine and Cell and Developmental Biology, and director […]

HER2 May Impact Lung Cancer Therapy

Friday, September 21st, 2012

Overcoming therapeutic resistance that inevitably develops is one of the major challenges in treating lung cancer. Non-small cell lung cancers that harbor mutations in the epidermal growth factor receptor (EGFR) are initially responsive to targeted therapies known as EGFR tyrosine kinase inhibitors (TKIs). However, most patients eventually develop resistance to these therapies. One such targeted […]

Cancer Wellness Program Launches ‘Thrivership’ Classes

Friday, September 21st, 2012

Adult cancer patients and survivors are invited to participate in Vanderbilt-Ingram Cancer Center’s new Thrivership Program, which is designed to restore wellness through physical activity, enhanced nutrition, body awareness and emotional well-being. During the six-week program, participants are invited to attend 90-minute classes which include guided exercise plus mindful movement along with interactive educational sessions […]